Skip to main content
Caplight Logo









AKSO Biopharmaceutical

AKSO Biopharmaceutical

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://aksobio.com

Company Overview

AKSO Biopharmaceutical operates in Healthcare & Life Sciences and is based in Los Angeles, California. It was founded in 2021.

AKSO Biopharmaceutical is a biopharmaceutical company that develops protein-based therapeutics for the treatment of cancer, autoimmune diseases, and genetic disorders using its proprietary DEEP engineering platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AKSO Biopharmaceutical Comparables

Compare AKSO Biopharmaceutical with similar companies based on industry and business-model similarity.

AKSO Biopharmaceutical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Novelogics Biotechnology
78%
EpimAb Biotherapeutics
76%
BioAtla
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AKSO Biopharmaceutical Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for AKSO Biopharmaceutical. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 87% MoM.

  • Apr 3, 2026

    Monthly visitors grew 4127% MoM, reaching 1.7K.

Book a demo to see all signals

For institutional investors. Book with your work email.

AKSO Biopharmaceutical Filings

Explore SEC and related filing metadata, where available.

AKSO Biopharmaceutical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AKSO Biopharmaceutical's valuation, stock price, and market status.

Is AKSO Biopharmaceutical a public or private company?

AKSO Biopharmaceutical is a private company.

What is the current stock price of AKSO Biopharmaceutical?

AKSO Biopharmaceutical is a private company, so its shares have no public market price. Caplight tracks AKSO Biopharmaceutical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AKSO Biopharmaceutical worth (valuation)?

Valuation information for AKSO Biopharmaceutical is not publicly available.

Can I buy AKSO Biopharmaceutical stock?

AKSO Biopharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AKSO Biopharmaceutical's last funding round?

Funding round information for AKSO Biopharmaceutical is not publicly available.

Who are the main investors in AKSO Biopharmaceutical?

Investor information for AKSO Biopharmaceutical is not publicly disclosed.

Will AKSO Biopharmaceutical IPO soon?

No public IPO plans have been announced for AKSO Biopharmaceutical.

How can I track AKSO Biopharmaceutical secondary market activity?

Caplight tracks bids, offers, and trades in AKSO Biopharmaceutical's shares on secondary markets.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range1
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?